Pembrolizumab in endometrial cancer: Where we stand now

Recently, immunotherapy has shown promising results in solid tumors. To the best of our knowledge, this is the first systematic review of published literature synthesizing all the available data and evaluating both the efficacy and safety of pembrolizumab in endometrial cancer. The present study was...

Descripción completa

Detalles Bibliográficos
Autores principales: Aravantinou-Fatorou, Aikaterini, Andrikopoulou, Angeliki, Liontos, Michael, Fiste, Oraianthi, Georgakopoulou, Vasiliki E., Dimopoulos, Meletios-Athanasios, Gavriatopoulou, Maria, Zagouri, Flora
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527559/
https://www.ncbi.nlm.nih.gov/pubmed/34691248
http://dx.doi.org/10.3892/ol.2021.13082

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8527559/
https://www.ncbi.nlm.nih.gov/pubmed/34691248
http://dx.doi.org/10.3892/ol.2021.13082

Ejemplares similares